Cancer glossary
CA-125 blood test: normal range, causes of a rise and next steps
CA-125 is a tumor marker used in ovarian cancer. What level is treated as the upper limit, what raises it without cancer, and why the trend matters most.
Written and medically reviewed by
Dr. Tara EinullaevaMedical oncologist, 9 years in practice. Credentials · reviewed 17 October 2026
In short
CA-125 is a protein whose blood level is often raised in ovarian cancer. The U.S. National Cancer Institute (NCI) lists three uses: helping with diagnosis, assessing response to treatment and checking for recurrence.
How it appears in your report
The lab report says “CA-125 — … U/mL” with a reference range. You may also see kU/L or IU/mL; for this marker the numbers are the same. In an oncologist’s notes you may read “marker response”, “CA-125 normalized” or “rising CA-125” — these always compare with earlier values.
What it means
| Reference point | Source |
|---|---|
| 0–35 U/mL — reference range | NHS laboratory (UHNM) |
| 35 IU/mL or higher in women with symptoms — reason for an ultrasound of the abdomen and pelvis | NICE (UK) |
The range depends on the test kit, so check it on your own report.
A rise without cancer can come from pregnancy, periods, endometriosis, pelvic inflammatory disease, ascites, pancreatitis, cirrhosis and, according to the MSD Manual, any inflammation of the peritoneum. The opposite also happens: with cancer, especially at an early stage, the marker can stay normal.
Does it affect treatment
In confirmed ovarian cancer, a CA-125 that was raised before treatment helps follow the trend. A fall usually goes along with a response; a steady rise is a reason to check for progression or recurrence. A single value is not a reason to change treatment: doctors look at the trend over several tests at the same lab and at imaging. The decision is made by your treating doctor. General rules for all markers are in the article on tumor markers. If you are unsure what your result means, I can go through it in a consultation.
Questions to ask your doctor
- Was my CA-125 raised before treatment, and will we track it?
- What change in the level would prompt further tests?
- What do we do if the marker rises but the CT shows no change?
Sources
- Tumor Marker Tests in Common Use — National Cancer Institute, 2023
- Cancer antigen 125 — University Hospitals of North Midlands NHS Trust
- Ovarian cancer: recognition and initial management (CG122) — NICE
- Tumor Immunodiagnosis — MSD Manual Professional Version
FAQ
Related terms
This is reference information and not a substitute for medical advice. Your doctor interprets each value in the context of your whole situation.
